Can Broadly Neutralizing Monoclonal Antibodies Lead to a Hepatitis C Virus Vaccine?


While licensed vaccines elicit protective antibody responses against a variety of viral infections, an effective vaccine for hepatitis C virus (HCV) has remained elusive. The extraordinary genetic diversity of HCV and the ability of the virus to evade the immune response have hindered vaccine development efforts. However, recent studies have greatly… (More)
DOI: 10.1016/j.tim.2018.04.002


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics